Rapport Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	1,326	649	-	-
Enterprise Value	821	330	-	-
Last Close Price	27.75	17.74	-	-
PB Ratio	2.58	2.12	-	-
P/TBV Ratio	2.59	2.12	-	-
Debt / Equity Ratio	0.02	0.01	0.05	0.54
Quick Ratio	35.84	34.82	16.75	18.74
Current Ratio	36.37	35.34	17.14	18.80
Return on Equity (ROE)	-23.41%	-35.09%	-43.36%	-
Return on Assets (ROA)	-15.88%	-22.07%	-24.18%	-
Return on Capital Employed (ROCE)	-21.10%	-27.10%	-24.70%	-19.60%
Earnings Yield	-7.39%	-12.07%	-	-
FCF Yield	-5.89%	-10.36%	-	-
Buyback Yield / Dilution	-190.80%	-1277.25%	-93.74%	-

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q